![Georg Nebgen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Georg Nebgen
Direttore/Membro del Consiglio presso
Kika Medical International Co.
Profilo
Dr. Nebgen is a of NGN Capital.
He joined from MPM Capital where he had previously been Principal at MPM Capital in Boston and Managing Director of MPM Capital GmbH.
Prior to this, Dr. Nebgen was with Schering-Plough Corporation, as Managed Care Area Manager for New England.
His responsibilities included contracting the reimbursement of Schering-Plough’s ethical pharmaceutical products and services with managed care organizations as well as leading sales pull-through activities of the field forces.
Prior to this, Dr. Nebgen had served in Schering-Plough's subsidiary in Switzerland as Business Unit Head, Oncology & Biotech and Business Unit Head, Cardiovascular & CNS.
Dr. Nebgen joined Schering-Plough from F.
Hoffmann-La Roche, where he led as Technical Project Leader the global research & development team for Invirase/Fortovase its NDA filing, FDA approval, and subsequent product launch in the United States.
Dr. Nebgen obtained his doctorate in Pharmaceutical Technology Sciences from the University of Bonn, Germany and his executive MBA from the University of St. Gallen, Switzerland.
Posizioni attive di Georg Nebgen
| Società | Posizione | Inizio |
|---|---|---|
Kika Medical International Co.
 Kika Medical International Co. Packaged SoftwareTechnology Services Provides web-based clinical study solutions | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Georg Nebgen
| Società | Posizione | Fine |
|---|---|---|
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Direttore/Membro del Consiglio | 02/07/2010 |
| SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 21/04/2008 |
Mannesmann Plastics Machinery GmbH
 Mannesmann Plastics Machinery GmbH Industrial MachineryProducer Manufacturing Manufactures plastics and rubber processing machines | Corporate Officer/Principal | - |
German-American Business Council | Presidente | 01/01/2003 |
Vivaldi Biosciences, Inc.
 Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Develops and markets vaccines | Direttore/Membro del Consiglio | - |
Formazione di Georg Nebgen
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
23
Relazioni di 1° grado
18
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 18 |
|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Aerovance, Inc.
 Aerovance, Inc. Medical DistributorsDistribution Services Develops drugs for respiratory and inflammatory diseases | Distribution Services |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Health Technology |
NGN Capital LLC
 NGN Capital LLC Investment ManagersFinance NGN Capital invests in companies located in the United States and Europe. The firm targets companies operating in the fields of healthcare and biotechnology. It participates in early and later stage capital requirements. | Finance |
Omrix Biopharmaceuticals, Inc.
 Omrix Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops biosurgical and immunotherapy solutions | Health Technology |
Kika Medical International Co.
Kika Medical International Co. Packaged SoftwareTechnology Services Provides web-based clinical study solutions | Technology Services |
Vivaldi Biosciences, Inc.
Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Develops and markets vaccines | Retail Trade |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Kourion Therapeutics
 Kourion Therapeutics Miscellaneous Commercial ServicesCommercial Services Researches and develops initiatives for stem cell technology, used for the regeneration of cardiac, neuronal, hepatic and bone tissues | Commercial Services |
Mannesmann Plastics Machinery GmbH
Mannesmann Plastics Machinery GmbH Industrial MachineryProducer Manufacturing Manufactures plastics and rubber processing machines | Producer Manufacturing |
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
University of St. Gallen
 University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Javelin Pharmaceuticals, Inc.
Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
University of Bonn
 University of Bonn Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Artisan Pharma, Inc.
 Artisan Pharma, Inc. Hospital/Nursing ManagementHealth Services Provides critical-care and hospital-based therapeutics to patients | Health Services |
ACT Biotech, Inc.
 ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs | Health Technology |
Valtech Cardio Ltd.
 Valtech Cardio Ltd. Medical SpecialtiesHealth Technology Develops devices for mitral valve repair and replacement | Health Technology |
German-American Business Council |
